Women's expectations and experiences of hormone treatment for sexual dysfunction

References

• Laumann E, Paik A, Rosen RC. Sexual dysfunction in the United States:prevalence and predictors. JAMA 1999;281:537–44
   PubMed Web of Science ®Google Scholar
• Hayes RD, Dennerstein L, Bennett CM, Fairley CK. What is the “true” prevalence of female sexual dysfunctions and does the way we assess these conditions have an impact?J Sex Med 2008;5:777–87
   PubMed Web of Science ®Google Scholar
• Moreira ED, Glasser DB, King R, Duarte FG, Gingell C, for the GSSAB Investigators’ Group. Sexual difficulties and help-seeking among mature adults in Australia: results from the Global Study of Sexual Attitudes and Behaviours. Sexual Health 2008;5:227–34
   PubMed Web of Science ®Google Scholar
• Biddle AK, West SL, D’Aloisio AA, Wheeler SB, Borisov NN, Thorp J. Hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden. Value Health 2009;12:763–72
   PubMed Web of Science ®Google Scholar
• Williams VS, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in two European countries: a cross-sectional patient survey. J Clin Psychiatry 2006;67: 204–10
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell RJ, LaChina M, Holden SL, Davis SR. The relationship between self-reported sexual satisfaction and general well-being in women. J Sex Med 2009;6:2690–7
   PubMed Web of Science ®Google Scholar
• Rosen RC, Maserejian NN, Connor MK, Krychman ML, Brown CS, Goldstein I. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women. Menopause 2012;19:396–405
   PubMed Web of Science ®Google Scholar
• Tan O, Bradshaw K, Carr BR. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review. Menopause 2012;19:109–17
   PubMed Web of Science ®Google Scholar
• Portman DJ, Bachmann GA, Simon JA. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause 2013;20:623–30
   PubMed Web of Science ®Google Scholar
• Simon JA, Lin VH, Radovich C, Bachmann GA. One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus. Menopause 2013;20:418–27
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. FDA approves Osphena for postmenopausal women experiencing pain during sex. FDA News Release, February 26, 2013. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm341128.htm. Accessed March 12, 2013
   Google Scholar
• Snabes MC, Simes SM. Approved hormonal treatments for HSDD: an unmet medical need. J Sex Med 2009;6:1846–9
   PubMed Web of Science ®Google Scholar
• Braunstein GD, Sundwall DA, Katz M, et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005;165:1582–9
   PubMed Web of Science ®Google Scholar
• Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105:944–52
   PubMed Web of Science ®Google Scholar
• Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226–33
   PubMed Web of Science ®Google Scholar
• Shifren J, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 study. Menopause 2006;13:770–9
   PubMed Web of Science ®Google Scholar
• Davis SR, van der Mooren MJ, van Lunsen RHW, et al. The efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause 2006;13:387–96
   PubMed Web of Science ®Google Scholar
• Davis SR, Moreau M, Kroll R, et al. Testosterone for low libido in menopausal women not taking estrogen therapy. N Engl J Med 2008;359:2005–17
   PubMed Web of Science ®Google Scholar
• Goldstat R, Briganti E, Tran J, Wolfe R, Davis S. Transdermal testosterone improves mood, well being and sexual function in premenopausal women. Menopause 2003;10:390–8
   PubMed Web of Science ®Google Scholar
• Davis SR, Papalia MA, Norman RJ, et al. Safety and efficacy of a testosterone metered-dose transdermal spray for treatment of decreased sexual satisfaction in premenopausal women: a placebo-controlled randomized, dose-ranging study. Ann Intern Med 2008;148:569–77
   PubMed Web of Science ®Google Scholar
• Nijland EA, Weijmar Schultz WC, Nathorst-Boos J, et al. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. J Sex Med 2008;5:646–56
   PubMed Web of Science ®Google Scholar
• Fooladi E, Davis SR. An update on the pharmacological management of female sexual dysfunction. Expert Opin Pharmacother 2012;13:2131–42
   PubMed Web of Science ®Google Scholar
• Sandelowski M. Whatever happened to qualitative description?Res Nursing Health 2000;23:334–40
   PubMed Web of Science ®Google Scholar
• Davison SL, Bell RJ, LaChina M, Holden SL, Davis SR. The relationship between self-reported sexual satisfaction and general well-being in women. J Sex Med 2009;6:2690–7
   PubMed Web of Science ®Google Scholar
• Hinchliff S, Gott M, Ingleton C. Sex, menopause and social context: a qualitative study with heterosexual women. J Health Psychol 2010;15:724–33
   PubMed Web of Science ®Google Scholar
• Manderson L. The social and cultural context of sexual function among middle-aged women. Menopause 2005;12:361–2
   PubMed Web of Science ®Google Scholar
• Evangelia N, Kirana P-S, Chiu G, Link C, Rosen R, Hatzichristou D. Level of bother and treatment-seeking predictors among male and female in-patients with sexual problems: a hospital-based study. J Sex Med 2010;7:700–11
   PubMed Web of Science ®Google Scholar
• Nappi RE. New attitudes to sexuality in the menopause: clinical evaluation and diagnosis. Climacteric 2007;10:105–8
   PubMed Web of Science ®Google Scholar
• Davis SR, Jane F. Drugs for the treatment of menopausal symptoms. Expert Opin Pharmacother 2010;11:1329–41
   PubMed Web of Science ®Google Scholar
• Catania JA, McDermott LJ, Pollack LM. Questionnaire response bias and face‐to‐face interview sample bias in sexuality research. J Sex Res 1986;22:52–72
   Web of Science ®Google Scholar
• Seale C. The Quality of Qualitative Research. London, UK: Sage, 1999
   Google Scholar
• Mitchell KR, King M, Nazareth I, Wellings K. Managing sexual difficulties: a qualitative investigation of coping strategies. J Sex Res 2010;48:325–33
   Web of Science ®Google Scholar
• Hinchliff S, Gott M, Ingleton C. Sex, menopause and social context. J Health Psychol 2010;15:724–33
   PubMed Web of Science ®Google Scholar
• Brezsnyak M, Whisman MA. Sexual desire and relationship functioning: the effects of marital satisfaction and power. J Sex Marital Ther 2004;30:199–217
   PubMed Web of Science ®Google Scholar
• Witting K, Santtila P, Varjonen M, et al. Female sexual dysfunction, sexual distress, and compatibility with partner. J Sex Med 2008;5:2587–99
   PubMed Web of Science ®Google Scholar
• Santtila P, Wager I, Witting K, et al. Discrepancies between sexual desire and sexual activity: gender differences and associations with relationship satisfaction. J Sex Marital Ther 2008;34:29–42
   PubMed Web of Science ®Google Scholar